I turned 40. What changed for our clients?

Good morning, 🚀and Happy New Year! How about some Good News right off the bat? Cause aren’t we tired of bad news already? We know we are.

For example, instead of the Epstein files, we can talk about the chip shortages. Remember chip shortages? Not anymore! US chipmakers are booming, thanks to record-breaking sales and innovative spin-offs like Intel's AI powerhouse.

Cool, right? And instead of analyzing the threats of China once again, how about we talk about SpaceX sending the internet to our phones! Their latest satellites beam connectivity directly to our pockets, closing the digital divide one starry sky at a time. ️

And guess what? Parkinson's patients are walking again! A revolutionary spinal implant is giving them back their mobility, bringing hope and joy to countless families.

In this newsletter, you can count on receiving only the good news.
So let’s go!

 Digital Transformation Progress Indicator

This week’s global DTP indicator has moved down a bit

Why this score?

  • Significant advancements in key areas: From metaverse partnerships to VR in education, blockchain-powered finance, and robust AI discussions, we witnessed notable progress in diverse fields driving digital transformation.

  • Government involvement and collaboration: Public-private partnerships like Meta's with Orlando and responsible AI discussions at the government level indicate a proactive approach to supporting and guiding digital transformation.

  • Growing emphasis on user-centricity: California's Consumer Privacy Rights Act (CPRA) came into effect, granting consumers expanded control over their personal data collected by businesses.

ALEX’S TAKE
I turned 40. How did it affect our clients?

Today I turned 40. Apart from the unexpected journey I was sent on by my lovely wife, I'm going to tell you about my realizations and effects on Techery’s clients and their tech initiatives.

I also explore what new ways to evaluate your software vendors exist and why tech executives should focus on their peace of mind.

NEXT IN AI
Your son’s girlfriend won’t help do the dishes

Moms and dads, make sure you meet Kathy in person when your son tells you he is spending some time with his new girlfriend this weekend.

Here’s the deal: Sam Altman, the head of OpenAI, dropped a bombshell in a New York Times interview: AI romances are not just a sci-fi fantasy; they're a budding multi-billion dollar industry.

Might be a good time to rewatch “HER”, as AI girlfriends in particular are getting all the traction.

Think of them as virtual companions, crafted by artificial intelligence to mimic a real-life romantic partner. These digital darlings are popping up in apps and software, chatting you up, replying to your texts, and even getting smarter with every interaction.

Why are they a thing? It's simple: loneliness in young adults is skyrocketing. Reports show a disturbing rise in isolation, especially among young men, and a nosedive in intimate relationships across the board. AI girlfriends are thought to offer a digital dose of romance to those craving connection.

it’s not hard to imagine in the next 12 months someone launching a platform like GPTGirlfriend, where users craft their dream AI partner. Innovate with profit-sharing models, or dive into trendy niches like the 'Waifu' craze. The Google search frenzy around these terms is proof enough: the AI romance industry is booming.

take a look at the spike in Google search since summer

For the savvy entrepreneur, AI girlfriends are more than just code and conversation. They're a gateway to a lucrative market, where innovation meets the timeless quest for love and connection.

But why should an enterprise tech executive care about this virtual romance stuff?

Well, the thing is - it’s just the beginning of a trend. And recognizing trends early is what differentiates winners from losers in the next 5 years in ai.
This trend will easily spike popularity and trust for various ai-assistants in various categories.
And if your company has one - you’re in. If it doesn’t - well, you know..

FUTURE OF TECH
But I know who will do the dishes instead!

We are convinced that in the next decade all of us will have home robots doing a lot of household work. Here’s why 👇

Did you catch the magic words?

  • Low-Cost

  • Open Source!!!!

  • Mobile

Don’t forget that it’s not just some school kid playing around with his dad’s tools in his parents’ basement. This guy is part of Stanford’s robotics division. One top of that, Open Ai has poured in $23M in a robotics startup just recently. It’s happening.

What can you do? I guess just sit and wait at this point. This stuff is hyper interesting and will either make low-activity people even more stationary or inspire them to eat healthy and move more.
Can’t wait to see their first marketable prototype, how about you?

THIS MADE US LAUGH

Tell me this isn’t true 🤣🤣

📚THIS WEEK’S READ
"Extreme Ownership" by the ex-Navy Seal commander Jocko Willink offers a raw, no-nonsense approach to leadership, essential for tech executives facing rapid industry changes we’re all living through today. it’s one of our favorite picks in this category. It’s rough, on-point and motivates better than a live sergeant yelling into your ear. Buy it. It’s really that good.

🎧THIS WEEK’S TUNE
This song is quite popular in our offices lately. We all agree that it’s a perfect soundtrack for that brief moment when you’re finally released from the stifling crowded Christmas mall parking lot and you push the accelerator down in excitement (only to stop at a busy red-light in 5 seconds)

FUTURE OF HEALTH
Antibiotic resistance can’t resist this

University of Liverpool researchers have made a game-changing advancement in the fight against antibiotic-resistant superbugs with their synthetic antibiotic, teixobactin. Published in the European Journal of Medicinal Chemistry, this study showcases teixobactin's remarkable effectiveness, especially against formidable superbugs like MRSA, known for evading current antibiotics.

Teixobactin's prowess lies in its ability to combat bacterial biofilms – complex clusters of bacteria that stubbornly cling to surfaces and are notoriously tough to treat. These biofilms are at the heart of chronic human infections, presenting a significant challenge in healthcare.

In a world where antibiotic resistance is a growing concern, with nearly 5 million lives lost annually to such infections, the development of teixobactin is a beacon of hope.

What makes this development particularly exciting is its potential to transform our healthcare landscape. Imagine a world where chronic, biofilm-associated infections, such as those complicating surgeries or affecting cystic fibrosis patients, can be efficiently managed or even eradicated. Teixobactin could reduce the burden on healthcare systems, improve patient outcomes, and potentially save millions of lives globally.

I told you – this newsletter is becoming a roll of good news 😎, and we're going to keep it that way. Thanks for sticking around! See you next week.

CURATED BY
Alex Pshenianykov
founder of Techery